Position in XLO
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$5,469,771
-$76,115,069 QoQ
Shares Held
650,389
-92.9% QoQ
Ownership
11.2%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GILEAD SCIENCES, INC. holds $2,117,784,503 across 6 Biotechnology names. XLO ranks #6 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
6,720,803 | $771,682,600 | |
| 2 | RCUS |
Arcus Biosciences, Inc.
|
31,424,760 | $678,774,816 | |
| 3 | LKFT |
Lakefront Biotherapeutics NV
|
16,707,477 | $501,224,310 | |
| 4 | ASMB |
Assembly Biosciences, Inc.
|
4,505,391 | $125,024,600 | |
| 5 | KYTX |
Kyverna Therapeutics, Inc.
|
4,126,119 | $35,608,406 | |
| 6 | XLO |
Xilio Therapeutics, Inc.
This page
|
650,389 | $5,469,771 |
All Filings in XLO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,469,771 | 650,389 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $81,584,840 | 9,105,451 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $107,462,532 | 9,105,451 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $101,044,746 | 10,613,944 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $86,683,893 | 9,105,451 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $92,292,851 | 9,105,451 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $121,739,879 | 9,105,451 | Shares | Sole | 2025-02-13 | |
| 2024-12-18 | $110,521,964 | 9,105,451 | Shares | Sole | 2024-12-19 | |
| No filing history on record for this holder in this stock. | ||||||